Expression of Nogo isoforms and Nogo-B receptor (NgBR) in non-small cell lung carcinomas.

Abstract:

BACKGROUND:Nogo-B was recently shown to be involved in proliferation, apoptosis and invasiveness of cancer cells, whereas its specific receptor (NgBR) was found to be up-regulated in estrogen receptor-α positive breast cancer. No data are currently available concerning their expression in non-small cell lung carcinomas (NSCLC). MATERIALS AND METHODS:Expression of Nogo isoforms and NgBR was studied in 191 NSCLC. RESULTS:Higher Nogo-A/B immunoreactivity was noted in cancer cells of squamous cell carcinomas (SQC) compared to adenocarcinomas (p<0.001). Stage II-IV tumors had the lowest Nogo-A/B expression (p<0.0001) compared to stage I cases. Nogo-A/B expression decreased with increasing SQC malignancy grade (p=0.026). Significant NgBR mRNA down-regulation was associated with larger primary tumor size (p=0.039), lymph node involvement (p=0.039) and advancement stage (p=0.0054). Low NgBR mRNA expression predicted poor patients outcome (p=0.029). CONCLUSION:The current data may point to the involvement of Nogo isoforms and NgBR in the pathogenesis of NSCLC.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Pula B,Werynska B,Olbromski M,Muszczynska-Bernhard B,Chabowski M,Janczak D,Zabel M,Podhorska-Okolow M,Dziegiel P

subject

Has Abstract

pub_date

2014-08-01 00:00:00

pages

4059-68

issue

8

eissn

0250-7005

issn

1791-7530

pii

34/8/4059

journal_volume

34

pub_type

杂志文章
  • Impact of a 21-Gene Recurrence Score Test on the Choice of Adjuvant Chemotherapy for Hormone Receptor-positive Early-stage Breast Cancer: A Prospective Study.

    abstract:BACKGROUND:Studies have recommended a 21-gene recurrence score (RS) to optimize adjuvant treatment for patients with early-stage breast cancer (EBC) with hormone receptor-positive (HR+) and human epidermal growth factor receptor-2 negative (HER2-) tumors. This study aimed to prospectively evaluate the impact of this RS...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11851

    authors: Zeng Y,Li Q,Qin T,Li S,Jin L,Wu J,Chen K,Deng H,Rao N,Liu Q,Su F,Jia W,Yao H

    更新日期:2017-08-01 00:00:00

  • Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.

    abstract:BACKGROUND:Genetic polymorphisms of carcinogen-metabolizing enzyme genes have been associated with the risk of oral squamous cell carcinoma and oral leukoplakia. The overexpression of p53 protein is the most common genetic alteration in head and neck cancer. In the present study the combined or isolated presence of glu...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Duarte EC,Ribeiro DC,Gomez MV,Ramos-Jorge ML,Gomez RS

    更新日期:2008-03-01 00:00:00

  • Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).

    abstract::The effect of treatment schedule on the antitumor activity of a new platinum derivative, glycolate-0,0'-diammineplatinum (II) (254S) compared with cis- diamminedichloroplatinum (II) (CDDP) was investigated using ascites L1210 leukemia and solid Lewis lung carcinoma. The drugs were given i.p. by three treatments: as a ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Suzumura Y,Kato T,Ueda R,Ota K

    更新日期:1989-07-01 00:00:00

  • Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects.

    abstract:BACKGROUND/AIM:Tyrosine kinase inhibitors are important in the treatment of metastatic renal cell cancer (mRCC). The aim of the study was to evaluate the costs and effects of sunitinib in mRCC. PATIENTS AND METHODS:A total of 81 mRCC patients who received first-line sunitinib therapy between 2010 and 2014 were recruit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13749

    authors: Vuorinen RL,Paunu N,Turpeenniemi-Hujanen T,Reunamo T,Jekunen A,Kataja V,Sintonen H,Purmonen T,Kellokumpu-Lehtinen PL

    更新日期:2019-10-01 00:00:00

  • Elderly Age Is Associated With More Conservative Treatment of Invasive Melanoma.

    abstract:BACKGROUND/AIM:Competing mortality risks complicate treatment of elderly melanoma patients potentially leading to conservative management, including no sentinel lymph node biopsy. As systemic immunotherapy offers justification for nodal evaluation, we examined treatment trends among elderly melanoma patients. PATIENTS...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14266

    authors: Bateni SB,Johns AJ,Gingrich AA,Gholami S,Bold RJ,Canter RJ,Kirane AR

    更新日期:2020-05-01 00:00:00

  • Radiation Gene-expression Signatures in Primary Breast Cancer Cells.

    abstract:BACKGROUND/AIM:In breast cancer (BC) care, radiation therapy (RT) is an efficient treatment to control localized tumor. Radiobiological research is needed to understand molecular differences that affect radiosensitivity of different tumor subtypes and the response variability. The aim of this study was to analyze gene ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12512

    authors: Minafra L,Bravatà V,Cammarata FP,Russo G,Gilardi MC,Forte GI

    更新日期:2018-05-01 00:00:00

  • Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.

    abstract:BACKGROUND:Dihydroceramide desaturase 1 (DES) is the enzyme responsible for converting dihydroceramide into ceramide in the de novo sphingolipid biosynthesis pathway. Dihydroceramide can inhibit ceramide channel formation to interfere with apoptosis. We have shown that following ceramide synthase knockdown, photodynami...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Breen P,Joseph N,Thompson K,Kraveka JM,Gudz TI,Li L,Rahmaniyan M,Bielawski J,Pierce JS,VAN Buren E,Bhatti G,Separovic D

    更新日期:2013-01-01 00:00:00

  • Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies.

    abstract::The present study was performed to investigate the prognostic impact of tumor resection on survival in children and adolescents with malignant gliomas. From the HIT-GBM data base of the Gesellschaft für Paediatrische Onkologie und Haematologie (GPOH), 85 pediatric patients with malignant non-pontine gliomas were analy...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kramm CM,Wagner S,Van Gool S,Schmid H,Sträter R,Gnekow A,Rutkowski S,Wolff JE

    更新日期:2006-09-01 00:00:00

  • pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer.

    abstract:BACKGROUND:The pS2 protein is involved in the maintenance of the integrity of the gastrointestinal tract. In breast cancer pS2 can be demonstrated in at least half of the tumors and probably reflects the functional status of ER. Several features make it likely that pS2 is involved in growth regulation. PATIENTS AND ME...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Jansen RL,Hupperets PS,Arends JW,Joosten-Achjanie SR,Volovics A,Hillen HF,Schouten HC

    更新日期:1998-01-01 00:00:00

  • Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: a Japanese study.

    abstract:BACKGROUND:Fulvestrant ('Faslodex') is a new type of oestrogen receptor (ER) antagonist that down-regulates the ER and has no known agonist effects. PATIENTS AND METHODS:In this open-label, Phase II trial, 30 postmenopausal Japanese women with hormone-sensitive advanced breast cancer, who had progressed on tamoxifen/t...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Watanabe T,Sano M,Ohno S,Inaji H,Nishimura R,Shin E,Nomura Y,Morris C

    更新日期:2004-03-01 00:00:00

  • Increased concentration of soluble E-selectin in the sera of breast cancer patients.

    abstract::E-selectin which is expressed on endothelial cells plays an important role in the adhesion of cancer cells to the vascular endothelium, being the ligand for a carbohydrate antigen expressed on cancer cells. In this study, the clinical usefulness of this protein was examined. E-selectin was expressed on the endothelial...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Matsuura N,Narita T,Mitsuoka C,Kimura N,Kannagi R,Imai T,Funahashi H,Takagi H

    更新日期:1997-03-01 00:00:00

  • Comparison of Cold Atmospheric Plasma Devices' Efficacy on Osteosarcoma and Fibroblastic In Vitro Cell Models.

    abstract:BACKGROUND/AIM:Cold atmospheric plasma (CAP) attenuates tumor cell proliferation and induces apoptosis in various cell lines. While exerting marginal effects on non-neoplastic cells this unfolds promising applications in cancer therapy. The aim of the study was to analyse the effects of different CAP sources and applic...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11968

    authors: Gümbel D,Suchy B,Wien L,Gelbrich N,Napp M,Kramer A,Ekkernkamp A,Daeschlein G,Stope MB

    更新日期:2017-10-01 00:00:00

  • Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial.

    abstract:BACKGROUND:The doxorubicin-docetaxel combination is active in breast cancer; the aim of the present study was to evaluate the complete response rate and safety profile of the doxorubicin and docetaxel regimen as first-line chemotherapy in metastatic breast cancer patients. PATIENTS AND METHODS:Forty-three patients ent...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Mattioli R,Lippe P,Massacesi C,Cappelletti C,Nacciarriti D,Bisonni R,Graziano F,Menichetti ET,Imperatori L,Testa E,Laici G,Balletra A,Silva RR

    更新日期:2004-09-01 00:00:00

  • Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.

    abstract:BACKGROUND:Breast cancer is associated with inflammatory processes based on an up-regulation of cyclooxygenase-2 (COX-2) expression. The antiproliferative effects of calcitriol (1,25(OH)(2)D(3)) mediated via the vitamin D receptor (VDR) render vitamin D a promising target in breast cancer therapy. First data suggest a ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Thill M,Fischer D,Hoellen F,Kelling K,Dittmer C,Landt S,Salehin D,Diedrich K,Friedrich M,Becker S

    更新日期:2010-05-01 00:00:00

  • Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer.

    abstract:BACKGROUND/AIM:To investigate whether high-dose-rate (HDR) intracavitary brachytherapy (IBT) dose ratios can predict treatment outcomes in patients with stage IIB cervical cancer. PATIENTS AND METHODS:Ninety-three patients treated with weekly cisplatin-based concurrent chemoradiotherapy and HDR IBT were analyzed. Pote...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11325

    authors: Cho O,Noh OK,Oh YT,Chang SJ,Chun M

    更新日期:2017-01-01 00:00:00

  • In vivo model of pseudomyxoma peritonei for novel candidate drug discovery.

    abstract::Pseudomyxoma peritonei (PMP) is a clinical condition characterized by diffuse intraabdominal spread of mucinous tumor implants that form on peritoneal surfaces. To complement the efficacy of cytoreductive surgery, an effective cytotoxic drug is required as an intraperitoneal agent for microscopic cytoreduction locoreg...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chua TC,Akther J,Yao P,Morris DL

    更新日期:2009-10-01 00:00:00

  • CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience.

    abstract:AIM:Hepatic resection for hepatic ovarian cancer metastases remains controversial. The purpose of this study was to evaluate the clinical outcome of CT-guided high dose rate brachytherapy (CT-HDRBT) for minimally invasive cytoreduction of isolated metachronous ovarian cancer metastases to the liver. PATIENTS AND METHO...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Collettini F,Poellinger A,Schnapauff D,Denecke T,Wust P,Braicu IE,Sehouli J,Hamm B,Gebauer B

    更新日期:2011-08-01 00:00:00

  • Optimum duration of oral adjuvant chemotherapy of HCFU for colorectal cancer; review of 5-year follow-up.

    abstract:PURPOSE:To investigate the optimal duration of oral HCFU administration for minimization of side effects induced by long-term administration. PATIENTS AND METHODS:In total, 155 patients allocated to two groups of different duration of the therapy were reviewed: twice or three times per day doses of oral HCFU (8 mg/Kg ...

    journal_title:Anticancer research

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Ito K,Kato T,Koike A,Miura K,Yamaguchi A,Sakou T,Takagi H

    更新日期:2000-11-01 00:00:00

  • Role of pesticides in the induction of tumor angiogenesis.

    abstract::Due to their estrogen-mimicking ability, pesticides are considered as prime etiological suspects of increasing tumor incidence, although a direct link is still undefined. The present study aimed to identify the effect of xenoestrogens (lindane, propoxur and endosulfan) at 20 mg/l each on tumorigenesis, by evaluating e...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bharathi SP,Raj HM,Jain S,Banerjee BD,Ahmed T,Arora VK

    更新日期:2013-01-01 00:00:00

  • Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.

    abstract::This study investigates the treatment management and survival of inoperable advanced non-small cell lung cancer (NSCLC) patients. The objective was to treat all patients with induction chemotherapy and then to stratify them for surgery, radiotherapy, second-line chemotherapy or supportive treatment. Of the 359 patient...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Stathopoulos GP,Dafni UG,Malamos NA,Rigatos S,Kouvatseas G,Moschopoulos N

    更新日期:1999-07-01 00:00:00

  • Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid.

    abstract::Gross cystic disease (GCD) represents an advanced form of fibrocystic disease of the breast. Bearers of macrocysts have been reported to be at risk of developing breast cancer. Natural killer (NK) cells are a lymphocyte subset deeply involved in immunosurveillance against neoplasia. We investigated whether breast cyst...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ardizzoja M,Masera RG,Tacconis P,Sartori ML,Arisio R,Massobrio M,Angeli A

    更新日期:1994-03-01 00:00:00

  • Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer.

    abstract::African-American women with breast cancer consistently show a shortened survival when compared with Caucasians with breast cancer, however it is not clear whether this is due to socioeconomic factors or to racial differences in tumor biology. Cyclin D1 overexpression has been demonstrated in 60-80% of female breast ca...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Joe AK,Arber N,Bose S,Heitjan D,Zhang Y,Weinstein IB,Hibshoosh H

    更新日期:2001-09-01 00:00:00

  • Modulation of PGE2-induced EP4 expression on snail signaling and the impact on epithelial-mesenchymal transition: significance of EP4 antagonism.

    abstract:BACKGROUND:Although significant accumulation of prostaglandin E(2) (PGE(2)) in the human prostate cancer tissues has been reported, there is lack of substantial evidence regarding the key role of PGE(2)-induced E-prostanoid-4 receptor (EP4) on Snail, a master regulator of epithelial mesenchymal transition (EMT). In thi...

    journal_title:Anticancer research

    pub_type: 杂志文章,收录出版

    doi:

    authors: Kim HN,Narayanan NK,Lasano S,Narayanan B

    更新日期:2011-12-01 00:00:00

  • Regulation of the proliferation of colon cancer cells by compounds that affect glycolysis, including 3-bromopyruvate, 2-deoxyglucose and biguanides.

    abstract::In previous studies performed by our group, we observed that 2-deoxyglucose blocked the acidification of the medium used for culture of colon cancer cells caused by incubation with biguanides and it had an additive inhibitory effect on growth. In the present work, we found that 3-bromopyruvate can also prevent the low...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lea MA,Qureshi MS,Buxhoeveden M,Gengel N,Kleinschmit J,Desbordes C

    更新日期:2013-02-01 00:00:00

  • Expression Pattern of Matrix Metalloproteinase 20 (MMP20) in Human Tumors.

    abstract:BACKGROUND/AIM:Matrix metalloproteinase 20 (MMP20) is a member of the family of matrix metalloproteinases. Under normal conditions the expression of MMP20 is restricted to ameloblasts and odontoblasts. In order to identify a possible expression of MMP20 under pathological conditions, we investigated three major human t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kraus D,Reckenbeil J,Perner S,Winter J,Probstmeier R

    更新日期:2016-06-01 00:00:00

  • The Clinical Efficacy of Enzalutamide in Metastatic Prostate Cancer: Prospective Single-center Study.

    abstract:BACKGROUND/AIM:To evaluate the effectiveness of enzalutamide in Italian patients with hormone-refractory metastatic castration-resistant prostate cancer, progressing after chemotherapy with docetaxel plus prednisone. PATIENTS AND METHODS:A total of 60 patients were enrolled. Reduction in serum prostate-specific antige...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:10.21873/anticanres.11472

    authors: Cicero G,DE Luca R,Dorangricchia P,Dieli F

    更新日期:2017-03-01 00:00:00

  • Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.

    abstract::Anaplastic lymphoma kinase (ALK) rearrangements were first implicated as driving mutations in non-small cell lung cancer in 2007. Since then, a number of novel, small-molecule inhibitors directed against the ALK receptor have demonstrated superiority over standard chemotherapies in the treatment of ALK rearrangement-p...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.12815

    authors: Millett RL,Elkon JM,Tabbara IA

    更新日期:2018-09-01 00:00:00

  • The primary in vitro antitumor screening of "half-mustard type" phenothiazines.

    abstract::The antitumor effects of "half-mustard type" phenothiazines were studied on 57 different tumor cell lines, including leukemias, non-small lung cancer, colon, central nervous system, ovarian, renal, breast, and prostate cancer, as well as melanoma cell cultures. Alkyl-urea derivatives of phenothiazines displayed in vit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wuonola MA,Palfreyman MG,Motohashi N,Kawase M,Gabay S,Nacsa J,Molnár J

    更新日期:1997-09-01 00:00:00

  • Sequential polychemotherapy in exocrine pancreatic cancer.

    abstract::The results of palliative chemotherapy in 162 patients suffering from exocrine pancreatic cancer are presented. They are mainly discussed with respect to the possibility of improving survival of exocrine pancreatic cancer patients by an efficacy-orientated sequential polychemotherapy (EOSP). In about 40% of the patien...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Klapdor R,Bahlo M,Babinski A,Broemel T,Müller C,Seutter R

    更新日期:2003-03-01 00:00:00

  • Granulocytapheresis as a possible cancer treatment.

    abstract::We assessed the effect of granulocyte apheresis in patients exhibiting increased granulocyte-to-lymphocyte ratio in order to overcome granulocytosis occurring in the terminal stages of malignancies. 17 patients with post-operative recurrent metastatic tumors including 6 gastric, 3 colonic, 2 rectal, 1 esophageal and 5...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Tabuchi T,Ubukata H,Sato S,Nakata I,Goto Y,Watanabe Y,Hashimoto T,Mizuta T,Adachi M,Soma T

    更新日期:1995-05-01 00:00:00